Bank of America’s Carlsmed CARL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Sell
15,583
-5,553
-26% -$67.1K ﹤0.01% 5459
2025
Q4
$261K Buy
21,136
+6,067
+40% +$80.8K ﹤0.01% 5212
2025
Q3
$202K Buy
+15,069
New +$206K ﹤0.01% 6274

Other funds holding CARL

Bank of America's CARL Position: Q1 2026 in Review

Bank of America reduced its Carlsmed (CARL) stake by 26% in Q1 2026, selling an estimated $67.1K and leaving 15,583 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #5459.

Bank of America first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $261K in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • Bank of America held 15,583 shares of Carlsmed worth $141K as of Q1 2026.
  • Bank of America sold 5,553 Carlsmed shares in Q1 2026, an estimated $67.1K.
  • Carlsmed made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5459 holding.
  • Bank of America first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • Bank of America's Carlsmed position peaked at $261K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.